$ELTP Love the news! Unfortunate to put it out when most won't be paying attention during the holiday break except for those ELTP junkies like us! Not expecting huge volume till after the New Year, but am willing to be surprised. Good time to add shares before they go parabolic.

$ELTP Nice buys happening, someone just picked up 175k shares, a little over $100k buy.....also, notice who's on the bid?

$ELTP MM INTL just soaked a bunch up....

"INTL FCStone Financial Ranked #1 Market Maker for International Equities Traded OTC for Fourth Consecutive Year"

$ELTP I've had similar thoughts.....

"BuddyGuise 11/06/24 9:42 AM
Post #413936 on Elite Pharmaceuticals Inc (ELTP)
$ELTP With the election over, I'm wondering about the potential buyer waiting. Was it because of tariff's? Are we talking a Euro partner looking for cheaper access to America? The global average tariff on pharmaceuticals has been declining over the years to around 3.5%. If Trump plans on increasing, might be incentive to scoop up an American company...."

Not a fan of gap ups, filled last week at the gap, will see if I need to sit on this one too, or will it close before end of day?

$ELTP  Whoop Whoop!

Senderos, Nas, mrwrm, Jimmy (and many others)- Congrats - names that have fought the good fight for a decade or more.  I'm so proud and happy for Elite, for us, and all those that listened to our crazy little rants on why they should invest here.  This is awesome!

$ELTP  "IQVIA reported annual sales for the twelve months ending September 2024 of $4.3 billion for the brand and generic market for this product."

Congrats to Nasrat and team....life changing!

$ELTP Congrats longs!  Generic Vyvanse approved!

$ELTP Hey Wench! I don't fault anyone for how they play the market. Taking profit is the name of the game and, besides those who bought recently when the RSI was pegged, we all should be green. If people don't have the stomache to hold through fins and cc, then likely they're traders and not investors. The point is, the over 6% takedown this morning was not some insider with a particular knowledge of the stock, but retail.

I do agree Dougs sale was surprising, especially coupled with expected news. Speculating why is pointless though, taking profit is the name of the game.

$ELTP B/A Spread is wide, small 1k hits bringing down. Small time manipulation imo. Shake of the tree's trying to get those last cheap shares before the moon shot. Initial 6% takedown done with less than 300k shares.

$ELTP With the election over, I'm wondering about the potential buyer waiting. Was it because of tariff's? Are we talking a Euro partner looking for cheaper access to America? The global average tariff on pharmaceuticals has been declining over the years to around 3.5%. If Trump plans on increasing, might be incentive to scoop up an American company....

$ELTP That is one nice candle!

$ELTP Could be INTL is holding it back while they accumulate. Suprised they were'nt more active after the Isreal news, seems like a smart group/individual. Bid soaking from what I see.

$ELTP With the news, wonder if we'll see mm INTL be more active today? I've been watching them, they're new to me, so I did some digging......

$ELTP. Congrats Elite on another approval and launch to the Elite Labs Label!

$ELTP lolzzzz Ask Stackers

$165,000 worth sitting at .389-.39

Bull Flag still active, the little FUD fire sale didn't quite do it, only expanded the range.

$ELTP The longer it gets wound up, the higher it will spring....this is gonna be fun!

Watching for the break out of the Bull Flag, only a matter of time.....

Gap closed, looking for the hammer! $ELTP

Is exactly what "they" have been working for by dominating the conversation with Fear Uncertainty and Doubt. Do you really think that if there was some malfeasance, the cockroaches of this world wouldn't have taken action already? The particular Mikah situation has been known for years, is stated in Q's and K's and NOW they want to discuss it and bring it to light? Or....is it because they know $ELTP is poised to finally be valuated at what it's worth and they are willing to do anything to try and get more shares. Notice how some will be pro $ELTP, particularly when there is a good chance for a ramp up of the stock price (before expected news or financial reports) and once the news/event comes, they shift to negative mode. Here's where they start to bash and call into question every move that could possibly create FUD. It's an old game, but effective. Creating fear and doubt discourages new buyers, they sell shares to bring the price down, then rebuy when the stock has been beaten lower. Then they turn positive again and the cycle continues.

We're looking at a year of possibly $50 million plus in revenues. No need to say any more than that.

“Just to give you a little history, in 2019, our revenues were $7.6 million for full year, full 12 months. In 2020 -- fiscal year 2020, it was $18 million. And then 2021, it was $25 million. 2022, it was $32 million and last fiscal year ended March 31st, 2023, it was $34 million.”
-Carter Ward-

“Last year's revenues were $34 million. Within nine months, ………… we've achieved $39 million, and we still have a quarter to go.”
-Nasrat Hakim-

“Just to give you a little history, in 2019, our revenues were $7.6 million for full year, full 12 months. In 2020 -- fiscal year 2020, it was $18 million. And then 2021, it was $25 million. 2022, it was $32 million and last fiscal year ended March 31st, 2023, it was $34 million.”
-Carter Ward-

“Last year's revenues were $34 million. Within nine months, ………… we've achieved $39 million, and we still have a quarter to go.”
-Nasrat Hakim-

Global M&A Trends in Health Industries
From Pricewaterhouse Coopers 2024 Outlook

"Pharmaceuticals and life sciences (PLS) and healthcare services (HCS) M&A remained resilient in 2023, with innovative companies that can drive value attracting substantial investor interest. We expect dealmaking to accelerate off this baseline in 2024, as has already been observed with a pickup in M&A activity toward the end of 2023 and in the first few weeks of 2024."

"Biotech acquisitions to fend off patent cliffs: Large-cap pharma companies will continue to face patent cliffs and gaps in their pipelines in the latter half of this decade and will look for M&A opportunities to achieve their growth plans. Small and midsize biotech companies that can fill in pipeline gaps in the back half of the decade will receive significant attention in 2024."
https://www.pwc.com/gx/en/services/deals/trends/health-industries.html

$5.1 Billion!!!

ELTP on 12/21/2023 “…announced the US Food and Drug Administration's (FDA) acceptance for review of an Abbreviated New Drug Application (ANDA) on December 21, 2023, for an undisclosed generic drug product in a class of medications known as central nervous stimulants.IQVIA reported annual sales for the twelve months ending June 2023 of $5.1 billion for the brand and generic market for this product.”
- PR 12/26/23 -

“Regarding the research and development pipeline, Elite has four ANDAs, filed under FDA reviews.”
-Nasrat Hakim-

“Last year's revenues were $34 million. Within nine months, ………… we've achieved $39 million, and we still have a quarter to go.”
-Nasrat Hakim-

For those visual learners out there....

“Just to give you a little history, in 2019, our revenues were $7.6 million for full year, full 12 months. In 2020 -- fiscal year 2020, it was $18 million. And then 2021, it was $25 million. 2022, it was $32 million and last fiscal year ended March 31st, 2023, it was $34 million.”
-Carter Ward-

“Regarding the research and development pipeline, Elite has four ANDAs, filed under FDA reviews.”
-Nasrat Hakim-

“Last year's revenues were $34 million. Within nine months, ………… we've achieved $39 million, and we still have a quarter to go.”
-Nasrat Hakim-

“Revenues are up 67%. Operating profits are up 77%. Nine months revenue are already more than last year's 12 months revenue.
Our working capital is increasing, our debt is low, and our balance sheet is strong and continues to strengthen.’
-Carter Ward-

Bollies Pinching..looking for a breakout...down to fill gap....or up up and away? $ELTP

Boom shock-a-lock-a $.1689 printed! Only wall I'm seeing on L2 is at $.18 for 225k...... $ELTP

Followed by a nice $24 k slap....$ELTP

Nice $25,837 slap....$ELTP

.123 window needs to close

$ELTP

Small gap from Oct 20th closed, would have been a great position to sit on and wait for the window to shut. It's a clear runway now and ready for an extended run, imo. Let's hear some news! $ELTP





https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173096144

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173096455

Small gap still in play on intraday, 5 minute chart. $ELTP

10/20/23 8:30 5 min candle high .1017
10/20/23 8:35 5 min candle low .1049







$ELTP